Skip to main content
. 2023 Dec 23;17:162–171. doi: 10.1016/j.xjon.2023.12.008

Table 1.

Demographic and clinical characteristics before and after March 11, 2020

Variable Pre–COVID-19 era
COVID-19 era
Total
P value
N = 3463 N = 4014 N = 7477
Age, y, mean (SD) 47.9 (15.2) 48.2 (13.1) 48.0 (14.1) .48
Race <.001
 White 2133 (61.6%) 1750 (43.6%) 3883 (51.9%)
 Black 568 (16.4%) 693 (17.3%) 1261 (16.9%)
 Hispanic 346 (10.0%) 1067 (26.6%) 1413 (18.9%)
 Asian 67 (1.9%) 129 (3.2%) 196 (2.6%)
 Middle Eastern or North African 22 (0.6%) 40 (1.0%) 62 (0.8%)
 Native American 45 (1.3%) 92 (2.3%) 137 (1.8%)
 Native Pacific Islander 9 (0.3%) 14 (0.3%) 23 (0.3%)
 Multiple 215 (6.2%) 167 (4.2%) 382 (5.1%)
 Other 58 (1.7%) 62 (1.5%) 120 (1.6%)
Sex <.001
 Female 1356 (39.2%) 1284 (32.0%) 2640 (35.3%)
 Male 2107 (60.8%) 2730 (68.0%) 4837 (64.7%)
Weight 96.1 (32.6) 98.7 (27.8) 97.5 (30.1) <.001
Year <.001
 2019 2691 (77.7%) 0 (0.0%) 2691 (36.0%)
 2020 772 (22.3%) 3496 (87.1%) 4268 (57.1%)
 2021 0 (0.0%) 518 (12.9%) 518 (6.9%)
COVID-19 positive <.001
 No 3461 (99.9%) 1237 (30.8%) 4698 (62.8%)
 Yes 2 (0.1%) 2777 (69.2%) 2779 (37.2%)
Rate 23.4 (7.4) 25.6 (7.1) 24.6 (7.3) <.001
FiO2 93.1 (15.3) 94.0 (13.1) 93.6 (14.2) .018
pH 7.25 (0.13) 7.27 (0.13) 7.26 (0.13) <.001
PCO2 63.0 (30.6) 66.2 (30.2) 64.8 (30.4) <.001
PO2 99.9 (102.2) 89.2 (85.0) 94.1 (93.3) <.001
HCO3 25.4 (6.9) 28.0 (7.2) 26.8 (7.2) <.001
SaO2 90.0 (83.0-95.0) 91.0 (85.0-95.0) 91.0 (84.0-95.0) .016
 Renal/pulmonary/other support 1503 (43.4%) 2551 (63.6%) 4054 (54.2%) <.001
 Vasoactives used 2105 (60.8%) 2264 (56.4%) 4369 (58.4%) <.001
Pre-ECLS arrest <.001
 No 3018 (87.1%) 3725 (92.8%) 6743 (90.2%)
 Unknown 43 (1.2%) 34 (0.8%) 77 (1.0%)
 Yes 402 (11.6%) 255 (6.4%) 657 (8.8%)

FiO2, Fraction of inspired oxygen; HCO3, bicarbonate; SaO2, oxygen saturation; ECLS, extracorporeal life support.

Unless indicated as a percentage, values within parentheses represent SDs.

Nonparametric test used, and value is median with interquartile range.